Export Snapshot

Minimum order

1 Bottle

HSN Code

300490

Origin

India

Lead time

On request

Port of dispatch

On request

Packaging

Standard export packaging

Shelf life / storage

As per product specification

Export markets served

US PH XG GB BD +46 others

Ability to customise

As per OEM brief

Values shown are for Radhakrushna Medicals.

Company Radhakrushna Medicals

Radhakrushna Medicals

"Radhakrushna Medicals: Your Destination for Critical Care & Speciality Medicines. Surgical Suture Vaccines  "

Registered address: Yavatmal, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Drugs & Pharmaceuticals.

View profile →

Established

2022

Employees

1–10

GST

27AEMPT2491Q2ZF

IEC code

AEMPT2491Q

Export markets

US PH XG GB BD +46 others

Member since

Feb 2026

Turnover

$50,000 - $250,000

Incorporation type

On request

DRUG LICENCE 20B DRUG LICENCE 21B RCMC-PHARMAXCIL

Product details

Description

ERLOLIEVA contains Erlotinib, an oral targeted anticancer medicine. It is a tyrosine kinase inhibitor (TKI) that selectively blocks the epidermal growth factor receptor (EGFR), thereby inhibiting tumor cell proliferation and survival—especially in EGFR-mutated cancers.

Uses

Erlotinib is used for the treatment of:

Non-small cell lung cancer (NSCLC) – EGFR-mutation positive (first-line or subsequent therapy)

Locally advanced or metastatic NSCLC – after failure of at least one prior chemotherapy regimen

Pancreatic cancer – in combination with gemcitabine

Side Effects

Common side effects:

•  Skin rash (acne-like)

•  Diarrhea

•  Loss of appetite

•  Fatigue

•  Nausea

Serious side effects:

•  Interstitial lung disease (rare but serious)

•  Severe skin reactions

•  Liver enzyme elevation

• Gastrointestinal perforation (rare)

Dosage

•   Standard dose: 150 mg orally once daily

•  Take on an empty stomach

    (At least 1 hour before or 2 hours after food)

•  Dose adjustment may be required based on tolerance or liver function.

NOTE: This medicine should be taken only under a doctor’s supervision.

Prescription Required

Description provided by Radhakrushna Medicals.

Erlotinib Tablets IP 150mg

ERLOLIEVA 150MG

Selective EGFR Tyrosine Kinase Inhibitor

EGFR mutation-positive Non-small cell lung cancer (NSCLC), Pancreatic cancer (with gemcitabine)

Tablet

Bottle of 30 tablets

Allieva Pharma Private Limited

India

Prescription Required

150 mg orally once daily on empty stomach

Specifications

Formulation

Oral Tablet

Strength

150 mg Erlotinib per tablet

Packing Size

30 tablets per bottle

Therapeutic Class

Anticancer, Tyrosine Kinase Inhibitor

Targeted Cancer Types

Non-small cell lung cancer (NSCLC), Pancreatic cancer

Dosage Instruction

Take 150 mg once daily on empty stomach

Side Effects

Skin rash, diarrhea, fatigue, nausea, rare interstitial lung disease

Storage Conditions

Store in a cool, dry place away from direct sunlight

Regulatory Status

Prescription drug - physician supervision required

Manufacturer Location

India

Use cases

Category

Pharmaceuticals > Anti-Cancer Drugs > Tyrosine Kinase Inhibitors

Primary application

Brand

Not specified

Product type

Product

Logistics & handling

Lead time

On request

Packaging

As per buyer requirement

Storage condition

As recommended by supplier

Origin

India

Form

As listed by supplier

Commercials Radhakrushna Medicals

Minimum order

1 Bottle

Lead time

On request

Payment terms

As per negotiated commercial agreement

Frequently asked by buyers

What cancers is ERLOLIEVA 150MG TAB primarily used to treat?

ERLOLIEVA 150MG TAB is primarily used to treat EGFR mutation-positive Non-small cell lung cancer (NSCLC) and in combination with gemcitabine for pancreatic cancer.

What is the recommended dosage and administration guidance for ERLOLIEVA 150MG TAB?

The standard recommended dose is 150 mg administered orally once daily on an empty stomach, at least 1 hour before or 2 hours after meals.

Are there specific side effects healthcare providers should monitor with ERLOLIEVA 150MG TAB?

Common side effects include skin rash, diarrhea, fatigue, and nausea, but healthcare providers should closely monitor for rare but serious adverse effects such as interstitial lung disease and severe skin reactions.

Is ERLOLIEVA 150MG TAB suitable for first-line treatment?

Yes, ERLOLIEVA 150MG TAB can be used as first-line therapy for patients with EGFR-mutated NSCLC or after failure of at least one previous chemotherapy regimen.

What are the storage recommendations for ERLOLIEVA 150MG TAB?

It should be stored in a cool, dry place away from direct sunlight to maintain stability and potency.

Question not answered? Sellers typically reply within 24–48 hours. Ask a question

What similar products are available in this category?

Browse all →

surbhi herbal tea - an ayurvedic formulation

Hetha

From $ 5.44

MOQ 1 Bottle

brahmi ghrita nasal drop

Hetha

From $ 5.10

MOQ 1 Bottle

himalayan badri gaumutra (gomutra) ark

Hetha

From $ 3.97

MOQ 1 Bottle

triphala gaumutra ark

Hetha

From $ 3.97

MOQ 1 Bottle

desi cow gaumutra ark / gomutra ark

Hetha

From $ 3.40

MOQ 1 Bottle

parijat aloevera gaumutra ark

Hetha

From $ 3.97

MOQ 1 Bottle

kachnar gaumutra ark

Hetha

From $ 3.97

MOQ 1 Bottle

tulsi giloy gaumutra ark

Hetha

From $ 3.97

MOQ 1 Bottle

More from Radhakrushna Medicals

Buyer guides & articles